Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes

Since its creation in 2000, Gavi, the Vaccine Alliance has leveraged its public-private structure - bringing together governments, UN agencies, private sector and civil society - to make new and underused vaccines more affordable and accessible to people in lower-income countries. With cost barriers largely removed, lower-income countries have embraced the opportunity to seek support for the introduction of life-saving vaccines. Since the initial Gavi-supported introductions of monovalent Hepatitis B vaccine in 2001, the picture has evolved significantly.